US20160310740A1 - Method for stimulating heart muscle activity during the refractory period - Google Patents
Method for stimulating heart muscle activity during the refractory period Download PDFInfo
- Publication number
- US20160310740A1 US20160310740A1 US14/695,237 US201514695237A US2016310740A1 US 20160310740 A1 US20160310740 A1 US 20160310740A1 US 201514695237 A US201514695237 A US 201514695237A US 2016310740 A1 US2016310740 A1 US 2016310740A1
- Authority
- US
- United States
- Prior art keywords
- heart muscle
- heart
- recited
- time
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 230000036279 refractory period Effects 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 22
- 210000004165 myocardium Anatomy 0.000 title claims description 52
- 230000004936 stimulating effect Effects 0.000 title claims description 17
- 230000000694 effects Effects 0.000 title description 2
- 210000005036 nerve Anatomy 0.000 claims abstract description 41
- 230000002889 sympathetic effect Effects 0.000 claims abstract description 38
- 230000000638 stimulation Effects 0.000 claims abstract description 31
- 230000008602 contraction Effects 0.000 claims abstract description 17
- 230000004217 heart function Effects 0.000 claims abstract description 17
- 230000001960 triggered effect Effects 0.000 claims abstract description 7
- 210000003462 vein Anatomy 0.000 claims description 9
- 230000003213 activating effect Effects 0.000 claims description 7
- SFLSHLFXELFNJZ-QMMMGPOBSA-N (-)-norepinephrine Chemical compound NC[C@H](O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-QMMMGPOBSA-N 0.000 abstract description 5
- 229960002748 norepinephrine Drugs 0.000 abstract description 5
- SFLSHLFXELFNJZ-UHFFFAOYSA-N norepinephrine Natural products NCC(O)C1=CC=C(O)C(O)=C1 SFLSHLFXELFNJZ-UHFFFAOYSA-N 0.000 abstract description 5
- 230000010247 heart contraction Effects 0.000 abstract description 3
- 230000028161 membrane depolarization Effects 0.000 abstract description 2
- 210000003748 coronary sinus Anatomy 0.000 description 3
- 230000007383 nerve stimulation Effects 0.000 description 3
- 230000004913 activation Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 230000022900 cardiac muscle contraction Effects 0.000 description 2
- 210000005240 left ventricle Anatomy 0.000 description 2
- 230000004220 muscle function Effects 0.000 description 2
- 210000005166 vasculature Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000009177 electrical depolarization Effects 0.000 description 1
- 238000010304 firing Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000008676 import Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 230000004044 response Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/3605—Implantable neurostimulators for stimulating central or peripheral nerve system
- A61N1/3606—Implantable neurostimulators for stimulating central or peripheral nerve system adapted for a particular treatment
- A61N1/36114—Cardiac control, e.g. by vagal stimulation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/02—Details
- A61N1/04—Electrodes
- A61N1/05—Electrodes for implantation or insertion into the body, e.g. heart electrode
- A61N1/0587—Epicardial electrode systems; Endocardial electrodes piercing the pericardium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
- A61N1/36507—Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by gradient or slope of the heart potential
Definitions
- the present invention pertains to systems and methods for improving heart muscle function. More particularly, the present invention pertains to systems and methods which stimulate sympathetic nerves to secrete norepinephrine during the absolute refractory period of a heart muscle cycle, to thereby improve heart muscle contraction.
- the present invention is particularly, but not exclusively, useful as a system or method wherein nerve stimulation in the absolute refractory period is triggered by a local electrical depolarization of the heart muscle.
- a normal heart muscle cycle i.e. a heartbeat
- a heartbeat is repetitive and is characterized by several well-known and distinctly identifiable mechanical and electrical characteristics.
- the heart muscle In its mechanical cycle, the heart muscle alternately functions to pump blood into the vasculature of a patient by its contractions (systole), and to receive blood from the vasculature by its relaxation (diastole).
- the heart muscle cycle is the result of an electrical cycle that is superposed on the mechanical cycle. Of immediate interest here, however, is the absolute refractory period.
- the heart muscle is not able to respond to an electrical stimulation.
- Sympathetic nerves on the epicardial surface of the heart can be electrically stimulated during the absolute refractory period to thereby secrete norepinephrine.
- the import here is that the secreted norepinephrine can then subsequently assist in controlling and improving a heart muscle contraction. It is, of course, essential to stimulate the sympathetic nerve during the heart's absolute refractory period so that the electrical and mechanical cycles of the heart are not disturbed.
- Identifying the appropriate time for electrically stimulating a sympathetic nerve must necessarily be established relative to the heart muscle cycle.
- the timing for nerve stimulation has been determined by the operation of a pacing device.
- U.S. Pat. No. 8,463,376, which issued to Curtis for an invention entitled “System and Method for Transvascular Activation of Cardiac Nerves with Automatic Restart,” discloses and claims the electrically paced stimulation of a heart muscle.
- the present invention now recognizes that the heart muscle itself creates natural signals (i.e. electrical events) which can be used to trigger a subsequent electrical stimulation of a sympathetic nerve. Importantly, this subsequent nerve stimulation can be timed to occur in the absolute refractory period of the heart muscle cycle.
- an object of the present invention to provide a system and method for electrically stimulating a sympathetic nerve of a patient in response to a naturally occurring electrical event of the heart muscle. Another object of the present invention is to electrically stimulate a sympathetic nerve of a patient using a single pulse, or multiple pulses, during the absolute refractory period of a heart muscle cycle to assist with a contraction of the patient's heart muscle. Still another object of the present invention is to provide a system and method for electrically stimulating a sympathetic nerve of a patient which is easy to use, is simple to manufacture and is commercially cost effective.
- a system and method are provided to improve the heart contractions of a patient during a heart function cycle (heartbeat).
- a deployment catheter is used to position an electrode and a sensor in an epicardial vein that is located on the epicardial surface of the heart. A proper positioning of the electrode and the sensor requires they be located adjacent a sympathetic nerve.
- the present invention detects a local electrical event (depolarization) of the heart muscle. Based on the occurrence of this local electrical event at a time t 0 , a stimulation interval, ⁇ t, is established.
- ⁇ t begins at the time t 0 , and it ends at a time t 1 during the absolute refractory period of the heart function cycle.
- the sympathetic nerve which is located on the epicardial surface of the heart, is stimulated. With this stimulation the sympathetic nerve will secrete norepinephrine to improve a subsequent contraction of the heart.
- a device of the present invention includes a sensor for detecting the local electrical event of the heart, at the time t 0 .
- a local electrical event is selected and used that occurs during a heart contraction, during diastole, in the patient's natural heart muscle cycle.
- the device also includes a timer that is activated at the time t 0 and is used for measuring the predetermined stimulation interval ⁇ t.
- the device includes a stimulator that is connected with an electrode for stimulating the sympathetic nerve with at least one electrical pulse at the time t 1 .
- the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is essentially less than about three times the intensity required for activating a contraction of the heart muscle.
- the system of the present invention may also include a pacing device which, along with the sensor, can be selectively connected by a switch with the stimulator.
- the pacing device when selected, is used to electronically establish t 0 .
- the switch can be used to selectively alternate between a connection of the stimulator with the sensor, or with the pacing device, the overall purpose and functionality of the system remains unchanged.
- Additional components for the device of the present invention include a voltage source that will generate the electrical pulse at the time t 1 .
- These components also include a computer for coordinating an operation of the stimulator with respective operations of the sensor, the pacing device, the switch, and the timer.
- a method for electrically stimulating a sympathetic nerve of a patient to improve heart function requires first positioning an electrode/sensor in an epicardial vein, on the epicardial surface of the heart, adjacent the sympathetic nerve. The electrode/sensor is then used to detect a local electrical event. Specifically, the local electrical event that is to be detected by the sensor needs to occur near the electrode and will result from the patient's natural heart muscle cycle.
- a computer can then be used to establish a predetermined stimulation interval ⁇ t that will extend from the start time t 0 , to a time t 1 .
- the computer can then activate the stimulator at the time t 1 .
- the purpose here is to electrically stimulate the sympathetic nerve with at least one electrical pulse, to thereby improve a subsequent contraction of the patient's heart muscle.
- an operation of the present invention requires consecutively repeating the stimulation interval ⁇ t for each heart function cycle.
- the stimulation interval ⁇ t that determines when a sympathetic nerve is to be stimulated is in an approximate range of 100-120 msec.
- the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is less than about three times the intensity required for activating a contraction of the heart muscle.
- FIG. 1 is a depiction of a system in accordance with the present invention shown together with the intended environment of its operation;
- FIG. 2 is a functional layout of the components employed in a system of the present invention
- FIG. 3 is a time-line depiction of a heart muscle cycle with an operation of the present invention superposed thereon in its relation to the absolute refractory period;
- FIG. 4 is a logic flow chart for the functional tasks that are required during an operation of the computer-controlled system of the present invention.
- a system for electrically stimulating a sympathetic nerve of a patient to improve heart function is shown and is generally designated 10 .
- the system 10 includes a deployment catheter 12 which has a sensor 14 and an electrode 16 that are mounted in combination at the distal end of the deployment catheter 12 .
- the system 10 also includes various electronic components which are disclosed below with reference to FIG. 2 . As disclosed below, these electronic components are mounted in the console 18 and interact with each other to provide operational control over the system 10 .
- the console 18 may be either extracorporeal or implantable.
- the console 18 may be part of a pacemaker or a defibrillator.
- a heart muscle 20 is shown as the surgical target for the present invention.
- Anatomically, a view of the diaphragmatic surface of the heart muscle 20 shows its coronary sinus 22 and several connecting veins.
- the posterior vein 24 of the left ventricle, and the middle cardiac vein 26 are shown.
- sympathetic nerve(s) 28 in the nervous system of which the nerve bundles 28 a, 28 b and 28 c are only exemplary.
- the nerves 28 are located on the epicardial surface of the left ventricle, and they are adjacent to either the coronary sinus 22 or one of the veins connected with the coronary sinus 22 (e.g. veins 24 or 26 ).
- a computer 30 is provided for the system 10 , and that the computer 30 is electronically connected with a switch 32 , a timer 34 , a stimulator 36 and a voltage source 38 .
- a pacing device 40 can also be electronically incorporated with the aforementioned components.
- the switch 32 , the timer 34 , the stimulator 36 , and the voltage source 38 , as well as the pacing device 40 can all be mounted on the extracorporeal console 18 .
- the sensor 14 and the electrode 16 are incorporated into the deployment catheter 12 .
- FIG. 2 For a disclosure of their interaction with each other, the components mentioned above are shown in FIG. 2 in their relationship with the heart muscle 20 .
- the sensor 14 and the electrode 16 are operationally shown in direct contact with the heart muscle 20 .
- the switch 32 is used to alternatively connect the sensor 14 or the pacing device 40 with the timer 34 .
- the stimulator 36 is energized by the voltage source 38 for a timed activation of the electrode 16 .
- the electrode 16 will stimulate a sympathetic nerve 28 on the heart muscle 20 .
- each pulse that is used to stimulate the sympathetic nerve 28 will have an intensity that is less than about three times the intensity required for activating a contraction of the heart muscle 20 .
- FIG. 3 The depiction of a normal heart function cycle (i.e. a heartbeat) is shown in FIG. 3 and is generally designated 42 .
- the heart function cycle 42 is depicted by an isoelectric line 44 .
- the absolute refractory period 46 of the heart function cycle 42 is shown in its overall relationship with the heart function cycle 42 .
- the absolute refractory period 46 is a period of time in which the heart muscle 20 is not able to respond to an electrical stimulation.
- the present invention requires there be a stimulation of a sympathetic nerve 28 during the absolute refractory period 46 .
- the system 10 of the present invention establishes a stimulation interval 48 that will begin with an electrical event 50 at a time t 0 and will end at a time t 1 in the absolute refractory period 46 when a sympathetic nerve 28 is stimulated.
- an exemplary electrical event 50 is shown on the isoelectric line 44 to occur at a time t 0 .
- the exact time for selection of an occurrence for the electrical event 50 is somewhat arbitrary. Preferably, however, it will be before and relatively near the beginning of the absolute refractory period 46 .
- a pacing device 40 can be employed to set the start time t 0 .
- ⁇ t will be in an approximate range of 100 to 120 msec. Again, note with reference to FIG. 3 that the time t 1 falls within the absolute refractory period 46 .
- FIG. 4 A logic flow chart for the tasks to be performed during an operation of the present invention is shown in FIG. 4 and is generally designated 52 .
- the inquiry block 54 questions whether the sensor 14 is being used. If so, task block 56 requires that the heart muscle function be monitored by the sensor 14 .
- inquiry block 58 asks whether an electrical event 50 has been detected. If not, the sensor 14 continues monitoring the heart function cycle 42 . On the other hand, if an electrical event 50 is detected, task block 60 requires the establishment of a stimulation interval 48 .
- the stimulation interval ⁇ t 48 extends from a time t 0 when the electrical event 50 is detected, to a time t 1 when a pulse(s) is(are) to be fired by the stimulator 36 to stimulate a sympathetic nerve 28 .
- a pacing device 40 rather than the sensor 14 , is used to trigger the stimulation interval 48 .
- inquiry block 54 together with task block 62 directs there be an engagement of the timer 34 with the pacing device 40 .
- the inquiry block 64 and task block 66 together, indicate that when the stimulation interval 48 has expired, the stimulator 36 is activated by the computer 30 to stimulate the sympathetic nerve 28 .
- the system 10 then proceeds to monitor the next heart function cycle 42 .
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Electrotherapy Devices (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Abstract
Description
- The present invention pertains to systems and methods for improving heart muscle function. More particularly, the present invention pertains to systems and methods which stimulate sympathetic nerves to secrete norepinephrine during the absolute refractory period of a heart muscle cycle, to thereby improve heart muscle contraction. The present invention is particularly, but not exclusively, useful as a system or method wherein nerve stimulation in the absolute refractory period is triggered by a local electrical depolarization of the heart muscle.
- A normal heart muscle cycle (i.e. a heartbeat) is repetitive and is characterized by several well-known and distinctly identifiable mechanical and electrical characteristics. In its mechanical cycle, the heart muscle alternately functions to pump blood into the vasculature of a patient by its contractions (systole), and to receive blood from the vasculature by its relaxation (diastole). Physiologically, the heart muscle cycle is the result of an electrical cycle that is superposed on the mechanical cycle. Of immediate interest here, however, is the absolute refractory period.
- During the absolute refractory period, which follows cell firing during diastole, and which is approximately 120-300 msec in duration, the heart muscle is not able to respond to an electrical stimulation. Sympathetic nerves on the epicardial surface of the heart, however, can be electrically stimulated during the absolute refractory period to thereby secrete norepinephrine. The import here is that the secreted norepinephrine can then subsequently assist in controlling and improving a heart muscle contraction. It is, of course, essential to stimulate the sympathetic nerve during the heart's absolute refractory period so that the electrical and mechanical cycles of the heart are not disturbed.
- Identifying the appropriate time for electrically stimulating a sympathetic nerve must necessarily be established relative to the heart muscle cycle. Heretofore, the timing for nerve stimulation has been determined by the operation of a pacing device. For example, U.S. Pat. No. 8,463,376, which issued to Curtis for an invention entitled “System and Method for Transvascular Activation of Cardiac Nerves with Automatic Restart,” discloses and claims the electrically paced stimulation of a heart muscle.
- The present invention now recognizes that the heart muscle itself creates natural signals (i.e. electrical events) which can be used to trigger a subsequent electrical stimulation of a sympathetic nerve. Importantly, this subsequent nerve stimulation can be timed to occur in the absolute refractory period of the heart muscle cycle.
- With the above in mind, it is an object of the present invention to provide a system and method for electrically stimulating a sympathetic nerve of a patient in response to a naturally occurring electrical event of the heart muscle. Another object of the present invention is to electrically stimulate a sympathetic nerve of a patient using a single pulse, or multiple pulses, during the absolute refractory period of a heart muscle cycle to assist with a contraction of the patient's heart muscle. Still another object of the present invention is to provide a system and method for electrically stimulating a sympathetic nerve of a patient which is easy to use, is simple to manufacture and is commercially cost effective.
- In accordance with the present invention, a system and method are provided to improve the heart contractions of a patient during a heart function cycle (heartbeat). To set up the system for its operation, a deployment catheter is used to position an electrode and a sensor in an epicardial vein that is located on the epicardial surface of the heart. A proper positioning of the electrode and the sensor requires they be located adjacent a sympathetic nerve.
- In an overview of the present invention, it is to be appreciated that, during each heart function cycle, the present invention detects a local electrical event (depolarization) of the heart muscle. Based on the occurrence of this local electrical event at a time t0, a stimulation interval, Δt, is established. In detail, Δt begins at the time t0, and it ends at a time t1 during the absolute refractory period of the heart function cycle. At the time t1, the sympathetic nerve, which is located on the epicardial surface of the heart, is stimulated. With this stimulation the sympathetic nerve will secrete norepinephrine to improve a subsequent contraction of the heart.
- Structurally, a device of the present invention includes a sensor for detecting the local electrical event of the heart, at the time t0. Typically, a local electrical event is selected and used that occurs during a heart contraction, during diastole, in the patient's natural heart muscle cycle. The device also includes a timer that is activated at the time t0 and is used for measuring the predetermined stimulation interval Δt. Recall, Δt extends between the start time t0 and the time t1 in the absolute refractory period of the patient's heart cycle (Δt=t1−t0). Further, the device includes a stimulator that is connected with an electrode for stimulating the sympathetic nerve with at least one electrical pulse at the time t1. Preferably, the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is essentially less than about three times the intensity required for activating a contraction of the heart muscle.
- For an alternate embodiment of the present invention, the system of the present invention may also include a pacing device which, along with the sensor, can be selectively connected by a switch with the stimulator. For this embodiment, when selected, the pacing device is used to electronically establish t0. Although the switch can be used to selectively alternate between a connection of the stimulator with the sensor, or with the pacing device, the overall purpose and functionality of the system remains unchanged.
- Additional components for the device of the present invention include a voltage source that will generate the electrical pulse at the time t1. These components also include a computer for coordinating an operation of the stimulator with respective operations of the sensor, the pacing device, the switch, and the timer.
- From a functional perspective, the methodology of the present invention is dependent on the heart function cycle. Accordingly, a method for electrically stimulating a sympathetic nerve of a patient to improve heart function requires first positioning an electrode/sensor in an epicardial vein, on the epicardial surface of the heart, adjacent the sympathetic nerve. The electrode/sensor is then used to detect a local electrical event. Specifically, the local electrical event that is to be detected by the sensor needs to occur near the electrode and will result from the patient's natural heart muscle cycle.
- Once a local electrical event is detected, a computer can then be used to establish a predetermined stimulation interval Δt that will extend from the start time t0, to a time t1. As noted above, the time t1 needs to fall in the absolute refractory period of the patient's natural heart muscle cycle (t1−t0=Δt). The computer can then activate the stimulator at the time t1. The purpose here, of course, is to electrically stimulate the sympathetic nerve with at least one electrical pulse, to thereby improve a subsequent contraction of the patient's heart muscle.
- With the above in mind, it is to be understood that an operation of the present invention requires consecutively repeating the stimulation interval Δt for each heart function cycle. Also, the stimulation interval Δt that determines when a sympathetic nerve is to be stimulated is in an approximate range of 100-120 msec. Further, the electrical pulse(s) for stimulating the sympathetic nerve has(have) a predetermined intensity that is less than about three times the intensity required for activating a contraction of the heart muscle.
- The novel features of this invention, as well as the invention itself, both as to its structure and its operation, will be best understood from the accompanying drawings, taken in conjunction with the accompanying description, in which similar reference characters refer to similar parts, and in which:
-
FIG. 1 is a depiction of a system in accordance with the present invention shown together with the intended environment of its operation; -
FIG. 2 is a functional layout of the components employed in a system of the present invention; -
FIG. 3 is a time-line depiction of a heart muscle cycle with an operation of the present invention superposed thereon in its relation to the absolute refractory period; and -
FIG. 4 is a logic flow chart for the functional tasks that are required during an operation of the computer-controlled system of the present invention. - Referring initially to
FIG. 1 , a system for electrically stimulating a sympathetic nerve of a patient to improve heart function is shown and is generally designated 10. As shown, thesystem 10 includes adeployment catheter 12 which has asensor 14 and anelectrode 16 that are mounted in combination at the distal end of thedeployment catheter 12. In addition to the mechanical components mentioned above, thesystem 10 also includes various electronic components which are disclosed below with reference toFIG. 2 . As disclosed below, these electronic components are mounted in theconsole 18 and interact with each other to provide operational control over thesystem 10. For purposes of the present invention, it is to be appreciated that theconsole 18 may be either extracorporeal or implantable. For example, as an implantable, theconsole 18 may be part of a pacemaker or a defibrillator. - Still referring to
FIG. 1 , aheart muscle 20 is shown as the surgical target for the present invention. Anatomically, a view of the diaphragmatic surface of theheart muscle 20 shows itscoronary sinus 22 and several connecting veins. In particular, theposterior vein 24 of the left ventricle, and the middlecardiac vein 26 are shown. Also shown are sympathetic nerve(s) 28 in the nervous system, of which the nerve bundles 28 a, 28 b and 28 c are only exemplary. Importantly, the nerves 28 are located on the epicardial surface of the left ventricle, and they are adjacent to either thecoronary sinus 22 or one of the veins connected with the coronary sinus 22 (e.g. veins 24 or 26). - Referring now to
FIG. 2 , it will be seen that acomputer 30 is provided for thesystem 10, and that thecomputer 30 is electronically connected with aswitch 32, atimer 34, astimulator 36 and avoltage source 38. Optionally, apacing device 40 can also be electronically incorporated with the aforementioned components. As will be best appreciated by cross-reference betweenFIG. 1 andFIG. 2 , theswitch 32, thetimer 34, thestimulator 36, and thevoltage source 38, as well as thepacing device 40, can all be mounted on theextracorporeal console 18. On the other hand, as disclosed above, thesensor 14 and theelectrode 16 are incorporated into thedeployment catheter 12. - For a disclosure of their interaction with each other, the components mentioned above are shown in
FIG. 2 in their relationship with theheart muscle 20. Specifically, thesensor 14 and theelectrode 16 are operationally shown in direct contact with theheart muscle 20. Depending on whether the operation ofsystem 10 is to rely on a paced event, which can be alternatively provided using thepacing device 40, theswitch 32 is used to alternatively connect thesensor 14 or thepacing device 40 with thetimer 34. Further, under the control of thecomputer 30, thestimulator 36 is energized by thevoltage source 38 for a timed activation of theelectrode 16. In turn, theelectrode 16 will stimulate a sympathetic nerve 28 on theheart muscle 20. As envisioned for the present invention, each pulse that is used to stimulate the sympathetic nerve 28 will have an intensity that is less than about three times the intensity required for activating a contraction of theheart muscle 20. - The depiction of a normal heart function cycle (i.e. a heartbeat) is shown in
FIG. 3 and is generally designated 42. As shown, theheart function cycle 42 is depicted by anisoelectric line 44. In this context, the absoluterefractory period 46 of theheart function cycle 42 is shown in its overall relationship with theheart function cycle 42. As discussed above, the absoluterefractory period 46 is a period of time in which theheart muscle 20 is not able to respond to an electrical stimulation. As also discussed above, the present invention requires there be a stimulation of a sympathetic nerve 28 during the absoluterefractory period 46. To do this, thesystem 10 of the present invention establishes astimulation interval 48 that will begin with anelectrical event 50 at a time t0 and will end at a time t1 in the absoluterefractory period 46 when a sympathetic nerve 28 is stimulated. - Still referring to
FIG. 3 an exemplaryelectrical event 50 is shown on theisoelectric line 44 to occur at a time t0. As envisioned by the present invention, the exact time for selection of an occurrence for theelectrical event 50 is somewhat arbitrary. Preferably, however, it will be before and relatively near the beginning of the absoluterefractory period 46. As indicated above, in an alternate embodiment of the present invention apacing device 40 can be employed to set the start time t0. In any event, once a time t0 has been determined for theelectrical event 50, or set by the pacingdevice 40, thestimulation interval 48 can be established. Mathematically expressed, t1−t0=Δt, wherein Δt is thestimulation interval 48. Preferably, Δt will be in an approximate range of 100 to 120 msec. Again, note with reference toFIG. 3 that the time t1 falls within the absoluterefractory period 46. - A logic flow chart for the tasks to be performed during an operation of the present invention is shown in
FIG. 4 and is generally designated 52. After the start of an operation, theinquiry block 54 questions whether thesensor 14 is being used. If so,task block 56 requires that the heart muscle function be monitored by thesensor 14. Next,inquiry block 58 asks whether anelectrical event 50 has been detected. If not, thesensor 14 continues monitoring theheart function cycle 42. On the other hand, if anelectrical event 50 is detected,task block 60 requires the establishment of astimulation interval 48. As disclosed above, thestimulation interval Δt 48 extends from a time t0 when theelectrical event 50 is detected, to a time t1 when a pulse(s) is(are) to be fired by thestimulator 36 to stimulate a sympathetic nerve 28. Recall, in an alternate embodiment of the present invention, apacing device 40, rather than thesensor 14, is used to trigger thestimulation interval 48. Thus, for the alternate embodiment,inquiry block 54 together withtask block 62 directs there be an engagement of thetimer 34 with the pacingdevice 40. In all embodiments, however, theinquiry block 64 andtask block 66, together, indicate that when thestimulation interval 48 has expired, thestimulator 36 is activated by thecomputer 30 to stimulate the sympathetic nerve 28. Thesystem 10 then proceeds to monitor the nextheart function cycle 42. - While the particular Method for Stimulating Heart Muscle Activity During the Refractory Period as herein shown and disclosed in detail is fully capable of obtaining the objects and providing the advantages herein before stated, it is to be understood that it is merely illustrative of the presently preferred embodiments of the invention and that no limitations are intended to the details of construction or design herein shown other than as described in the appended claims.
Claims (20)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/695,237 US20160310740A1 (en) | 2015-04-24 | 2015-04-24 | Method for stimulating heart muscle activity during the refractory period |
US14/815,711 US20160310724A1 (en) | 2015-04-24 | 2015-07-31 | System and method for electrode placement in the pericardial sac of a patient |
JP2017555459A JP2018512971A (en) | 2015-04-24 | 2016-02-22 | Method for stimulating myocardial activity during the refractory period |
EP16783536.2A EP3285853B1 (en) | 2015-04-24 | 2016-02-22 | Device for stimulating heart muscle activity during the refractory period |
PCT/US2016/018867 WO2016171790A1 (en) | 2015-04-24 | 2016-02-22 | Method for stimulating heart muscle activity during the refractory period |
US16/653,538 US11565113B2 (en) | 2015-04-24 | 2019-10-15 | Method for stimulating heart muscle activity during the refractory period |
JP2019004243U JP3224852U (en) | 2015-04-24 | 2019-11-08 | Methods for stimulating myocardial activity during the refractory period |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14/695,237 US20160310740A1 (en) | 2015-04-24 | 2015-04-24 | Method for stimulating heart muscle activity during the refractory period |
Related Child Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/815,711 Continuation-In-Part US20160310724A1 (en) | 2015-04-24 | 2015-07-31 | System and method for electrode placement in the pericardial sac of a patient |
US16/653,538 Division US11565113B2 (en) | 2015-04-24 | 2019-10-15 | Method for stimulating heart muscle activity during the refractory period |
Publications (1)
Publication Number | Publication Date |
---|---|
US20160310740A1 true US20160310740A1 (en) | 2016-10-27 |
Family
ID=57143350
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US14/695,237 Abandoned US20160310740A1 (en) | 2015-04-24 | 2015-04-24 | Method for stimulating heart muscle activity during the refractory period |
US16/653,538 Active 2036-05-08 US11565113B2 (en) | 2015-04-24 | 2019-10-15 | Method for stimulating heart muscle activity during the refractory period |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US16/653,538 Active 2036-05-08 US11565113B2 (en) | 2015-04-24 | 2019-10-15 | Method for stimulating heart muscle activity during the refractory period |
Country Status (4)
Country | Link |
---|---|
US (2) | US20160310740A1 (en) |
EP (1) | EP3285853B1 (en) |
JP (2) | JP2018512971A (en) |
WO (1) | WO2016171790A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11167145B2 (en) | 2019-10-30 | 2021-11-09 | Guy P. Curtis And Frances L. Curtis Trust | System and method for indirect measurement of ventricular contractility |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040199210A1 (en) * | 2002-06-12 | 2004-10-07 | Shelchuk Anne M. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US20080132966A1 (en) * | 2006-12-05 | 2008-06-05 | G&L Consulting, Llc | Stimulation of coronary artery baroreceptors |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP4252830B2 (en) | 2003-03-24 | 2009-04-08 | テルモ株式会社 | Heart treatment equipment |
US7233824B2 (en) * | 2003-10-07 | 2007-06-19 | Medtronic, Inc. | Secure and efficacious therapy delivery for an extra-systolic stimulation pacing engine |
US7570999B2 (en) * | 2005-12-20 | 2009-08-04 | Cardiac Pacemakers, Inc. | Implantable device for treating epilepsy and cardiac rhythm disorders |
JP5052596B2 (en) * | 2006-03-29 | 2012-10-17 | ディグニティー ヘルス | Synchronization of vagus nerve stimulation by patient's cardiac cycle |
US8478406B2 (en) * | 2006-04-24 | 2013-07-02 | Medtronic, Inc. | Apparatus and methods of delivering an enhanced refractory period stimulation therapy |
US20080269819A1 (en) * | 2007-04-26 | 2008-10-30 | Xiaohong Zhou | Discrimination of supraventricular tachycardia from ventricular tachycardia |
US8463376B2 (en) | 2008-08-12 | 2013-06-11 | Guy P. Curtis | System and method for transvascular activation of cardiac nerves with automatic restart |
JP2011103981A (en) * | 2009-11-13 | 2011-06-02 | Olympus Corp | Nerve stimulation device |
US8504158B2 (en) * | 2011-05-09 | 2013-08-06 | Medtronic, Inc. | Phrenic nerve stimulation during cardiac refractory period |
EP2717962B1 (en) * | 2011-06-07 | 2017-04-19 | The Guy P. Curtis and Frances L. Curtis Trust | System for transvascular activation of cardiac nerves with automatic restart |
JP5846816B2 (en) * | 2011-09-15 | 2016-01-20 | オリンパス株式会社 | Nerve stimulator |
-
2015
- 2015-04-24 US US14/695,237 patent/US20160310740A1/en not_active Abandoned
-
2016
- 2016-02-22 WO PCT/US2016/018867 patent/WO2016171790A1/en active Application Filing
- 2016-02-22 JP JP2017555459A patent/JP2018512971A/en active Pending
- 2016-02-22 EP EP16783536.2A patent/EP3285853B1/en active Active
-
2019
- 2019-10-15 US US16/653,538 patent/US11565113B2/en active Active
- 2019-11-08 JP JP2019004243U patent/JP3224852U/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040199210A1 (en) * | 2002-06-12 | 2004-10-07 | Shelchuk Anne M. | Vagal stimulation for improving cardiac function in heart failure or CHF patients |
US20080132966A1 (en) * | 2006-12-05 | 2008-06-05 | G&L Consulting, Llc | Stimulation of coronary artery baroreceptors |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11167145B2 (en) | 2019-10-30 | 2021-11-09 | Guy P. Curtis And Frances L. Curtis Trust | System and method for indirect measurement of ventricular contractility |
Also Published As
Publication number | Publication date |
---|---|
US20200398056A9 (en) | 2020-12-24 |
EP3285853A4 (en) | 2018-09-05 |
EP3285853B1 (en) | 2021-07-28 |
JP3224852U (en) | 2020-01-23 |
JP2018512971A (en) | 2018-05-24 |
US20200038661A1 (en) | 2020-02-06 |
US11565113B2 (en) | 2023-01-31 |
WO2016171790A8 (en) | 2017-01-19 |
WO2016171790A1 (en) | 2016-10-27 |
EP3285853A1 (en) | 2018-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2558160B1 (en) | Autonomic modulation using transient response with intermittent neural stimulation | |
US9168382B2 (en) | Method and apparatus for selective his bundle pacing | |
EP0727241B1 (en) | Device for heart stimulation | |
US8209013B2 (en) | Therapeutic electrical stimulation that avoids undesirable activation | |
EP2153867A2 (en) | System and method for transvascular activation of cardiac nerves to improve heart function | |
KR102630590B1 (en) | Methods and systems for treating cardiac dysfunction | |
JP2014533578A (en) | Management of cross therapy sensing in implantable devices for multiple therapy | |
JP4629673B2 (en) | Electrically effective neural excitatory stimulation | |
CN109068982A (en) | The system of probe and the stimulation vagal probe of epileptic including the electric discharge of detection operation current potential cluster | |
US11565113B2 (en) | Method for stimulating heart muscle activity during the refractory period | |
US11389656B2 (en) | Active implantable medical device for nerve stimulation therapy with dynamic adjustment of stimulation periods | |
US7321794B2 (en) | Method and system for treating atrial fibrillation | |
US10744327B2 (en) | Active electrical nerve stimulation medical device, with automatic charge compensation control | |
US8214033B2 (en) | Interferential cardiac preconditioning and depolarization | |
US8463376B2 (en) | System and method for transvascular activation of cardiac nerves with automatic restart | |
EP2717962B1 (en) | System for transvascular activation of cardiac nerves with automatic restart | |
US20160310724A1 (en) | System and method for electrode placement in the pericardial sac of a patient | |
US20230173281A1 (en) | Hypertension his bundle pacing | |
US8744558B2 (en) | Method and apparatus for providing ipselateral therapy | |
JP2005013504A (en) | Heart treatment device | |
WO2017023382A1 (en) | System and method for electrode placement in the pericardial sac of a patient |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: GUY P. CURTIS AND FRANCES L. CURTIS TRUST, CALIFOR Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:CURTIS, GUY P.;REEL/FRAME:035855/0254 Effective date: 20150603 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: FINAL REJECTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: RESPONSE AFTER FINAL ACTION FORWARDED TO EXAMINER |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: ADVISORY ACTION MAILED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |